锁定长期授权收益 华大智造拟5000万美元交易优化财务结构

Core Viewpoint - The company plans to sell 100% of its subsidiary Complete Genomics, Inc. for approximately $50 million, while also upgrading sequencing technology licensing in North America, marking a strategic shift towards technology output and improved financial performance [2][3]. Financial Aspects - The transaction will generate multiple financial benefits, including $50 million from the equity sale, a $20 million upfront payment for technology licensing due by November 2025, and an additional $20 million milestone payment, enhancing cash flow and current profits [3]. - The divestiture of the North American business unit is expected to reduce annual operating losses by $40 million to $50 million, thereby improving overall profitability [3]. - The licensing fee rate for the StandardMPS technology is set at 8.71%, with a tiered revenue-sharing model based on global net sales of the partner's products, creating a stable long-term cash flow [3]. Business and Strategic Aspects - The transaction optimizes global layout and upgrades the business model, allowing the company to leverage local partners' resources and compliance capabilities for North American market operations [3]. - The deal transforms high-volatility direct market operations into structured licensing income, reducing operational uncertainty and enhancing compliance [3]. - The reverse licensing and intellectual property isolation mechanisms strengthen the company's technological security [3]. Industry Perspective - Analysts suggest that this transaction redefines the company's valuation logic, moving beyond the perception of being merely a device manufacturer to a model akin to leading firms in innovative pharmaceuticals [4]. - The transaction optimizes the allocation of non-core mature technologies and loss-making assets, improving asset return rates and demonstrating the international competitiveness of domestic high-tech enterprises [4]. - This move serves as a benchmark for Chinese scientific instrument technology going global, providing a valuable case for value realization in the industry and opening up significant valuation potential [4].